Norton Rose Fulbright
Norton Rose Fulbright provides a full scope of legal services to the world’s preeminent corporations and financial institutions. The global law firm has more than 3,000 lawyers advising clients across more than 50 locations worldwide, including London, Houston, New York, Toronto, Mexico City, Hong Kong, Sydney and Johannesburg, covering Europe, the United States, Canada, Latin America, Asia, Australia, Africa and the Middle East.
Deal insurance demand rises as buyers guard against M&A risk
Deal insurance demand rises as buyers guard against M&A risk
Valuation gaps topped dealmakers’ concerns at 48%.
Broker deals set stage for faster 2025 insurance M&A
Strategic buyers and private equity investors are likely to remain active.
Chinese insurers deem it wise to move to alternative investments
Analysts see new regulations driving a conservative shift as insurers seek stability amidst volatile markets.
Most Read
1. Singapore digital economy surges to $144.1b, now 19% of GDP 2. Stablecoin payments are going mainstream. Hong Kong and APAC are showing how 3. Only 9% of Singapore online shoppers qualify as savvy, report says 4. Why digital assets are set to become mainstream in APAC 5. Rethinking fleet ownership in a changing business landscapeResource Center
Read Here
Advertise
Sign Up
Awards
Nov
11
Feb
23
Event News
The healthcare provider earned recognition for its physical clinic expansion and digital platform enhancements.
Commentary
Rethinking fleet ownership in a changing business landscape
Stablecoin payments are going mainstream. Hong Kong and APAC are showing how
Why regional collaboration is essential for Asia’s next wave of innovation
Why digital assets are set to become mainstream in APAC
Bitcoin’s latest hacks expose where trust really sits in Asia
We're getting very good at the business we're trying to escape
The hidden role of gold nanoparticles in Southeast Asian diagnostics
How homegrown brands are redefining premium in Asia
Why AI sovereignty is a practical discipline for Southeast Asia’s scaleups
Why healthcare must solve for patient behaviour, not just treatment